All News

Ibrance gained full FDA approval for the treatment of some patients with breast cancer.

Fewer people are dying from cancer than years ago, according to a recent study.

Mutations might be the answer as to why sidedness has an effect on colorectal cancer outcomes.

A debate among health care providers has ensued over the cardiotoxicity risk that is associated with anthracycline regimens for patients with breast cancer. Sara A. Hurvitz, M.D., weighs in.

An ongoing trial is seeking to find out if a patient with an MPN can improve their health status through nutritional interventions.

Tagrisso (osimertinib) was granted a regular Food and Drug Administration (FDA) approval to treat some patients with lung cancer.

Some patients experience fatigue as a side effect of cancer treatment. And for some of us, fatigue lingers on and on and on.

Sometimes life is about learning to enjoy those little moments despite all the rest.

Andre Goy, M.D., discusses some exciting advances in mantle cell lymphoma (MCL).

When someone faces a cancer diagnosis during the period of social maturation, the impacts can be lasting, according to a recent study.

What role will immunotherapy play in the future treatment of GI cancers? CURE spoke to Brian Hemphill, M.D., to find out.

When your cancer is just like the common cold.

How does one heal after a cancer diagnosis?

All members of the FDA’s Oncologic Drugs Advisory Committee (ODAC) voted to approve Rituxan for the treatment of some blood cancers.

Mohammad Jahanzeb, M.D., discusses the SystHERs study, which is looking closely at current treatment methods for HER2- positive metastatic breast cancer (MBC).

After publishing them in October 2016,the National Comprehensive Cancer Network (NCCN) is already seeking to update and expand their guidelines for diagnosing and treating patients with myeloproliferative neoplasms (MPNs).

Choosing a prosthesis requires a little work on the part of the wearer. Understanding options is not only helpful, but necessary.

What about hope? Don’t kill hope. Breast cancer and melanoma survivor shares what helped at the time of diagnosis and early on in her cancer treatment.

Adam M. Brufsky, M.D., Ph.D., discusses bone-targeted agents in breast cancer, and what we can expect for the future of this kind of therapy.

Women with breast cancer who were treated with AIs may experience sexual side effects, but there are steps that can be taken to improve their quality of life.

A recent study investigated racial and ethnic disparities in guideline-based care for cervical cancer.

It’s your choice to explain how your cancer battle has affected you, but it’s their choice to try and understand.

On learning to accept the ups and down of the journey despite how you feel

The FDA has approved Zejula (niraparib) for treatment of patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer in the maintence setting.

Kula for Karma, a nonprofit organization, offers yoga programs designed to aid patients with cancer as well as medical professionals, first responders and others, manage stress and improve quality of life.

In an interview with CURE, lead study author Scott Tagawa, M.D., discussed the latest findings with sacituzumab govitecan in patients with metastatic urothelial cancer.

Michael F. Press, M.D., Ph.D., shed light on the role of the receptor in breast cancer in a presentation during the 2017 Miami Breast Cancer Conference.

As the treatment landscape of head and neck cancer has changed significantly over the past year, immunotherapy has emerged as a key player in patient care.